Suven LifeSciences has announced its third quarter results of FY10. Its profit after tax (PAT) went up to Rs 71.96 lakh versus Rs 27.49 lakh, (YoY).
Revenues fell 16.6% to Rs 28.9 crore from Rs 34.7 crore and operating profit margin improved to 14.4% versus 4.2%.
Highlights
-CRAMS business down to Rs 21.33 crore versus Rs 25.9 crore -Services revenue down to Rs 7.65 crore versus Rs 8.91 crore -R&D EBIT Loss is Rs at 9.7 crore versus Rs 7.39 crore -Total expenses down 18.8% to Rs 27 crore versus Rs 33.2 crore -Raw Material costs down 37% to Rs 8.6 crore -PAT saved by tax inflow of Rs 1.01 crore versus Rs 1.28 crore -Interest costs lower at Rs 89 lakhs versus Rs 1.4 crore